Novel cinobufagin oxime ether derivatives as potential Na+/K+-ATPase inhibitors: Synthesis, biological screening and molecular docking

Guangping Liang , Tseyu Chung , Jinhua Guo , Rongrong Zhang , Wei Xü , Jason T. C. Tzen , Renwang Jiang

Chemical Research in Chinese Universities ›› 2017, Vol. 33 ›› Issue (3) : 378 -383.

PDF
Chemical Research in Chinese Universities ›› 2017, Vol. 33 ›› Issue (3) : 378 -383. DOI: 10.1007/s40242-017-6487-1
Article

Novel cinobufagin oxime ether derivatives as potential Na+/K+-ATPase inhibitors: Synthesis, biological screening and molecular docking

Author information +
History +
PDF

Abstract

Some cinobufagin oxime ether derivatives as potential Na+/K+-ATPase inhibitors were synthesized by following the side chain of istaroxime. These compounds inhibit Na+/K+-ATPase in a dose-dependent manner. Compound 3c with an oxyethylamine side chain that is the same as that of istaroxime showed the most potent inhibition, which was stronger than compound 3a with only hydroxyoxime moiety at C-3 and compound 3b with a methylated hydroxyoxime moiety. Molecular docking was used to explore the binding modes of the target compounds with Na+/K+-ATPase, which suggested that the longer ethyl amine group at C-3 oxime moiety of compound 3c could make stronger interaction with Na+/K+-ATPase via intermolecular charge-charge and H-bond interaction as compared with other derivatives.

Keywords

Cinobufagin / Istaroxime / Na+/K+-ATPase / Molecular docking

Cite this article

Download citation ▾
Guangping Liang, Tseyu Chung, Jinhua Guo, Rongrong Zhang, Wei Xü, Jason T. C. Tzen, Renwang Jiang. Novel cinobufagin oxime ether derivatives as potential Na+/K+-ATPase inhibitors: Synthesis, biological screening and molecular docking. Chemical Research in Chinese Universities, 2017, 33(3): 378-383 DOI:10.1007/s40242-017-6487-1

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Skou J. C. Angew. Chem. Int. Ed., 1998, 37: 2320.

[2]

Kaplan J. H. Annu. Rev. Biochem., 2002, 71: 511.

[3]

Laursen M., Gregersen J. L., Yatime L., Nissen P., Fedosova N. U. P. Natl. Acad. Sci. USA, 2015, 112: 1755.

[4]

Bavishi C., Khan A. R., Ather S. Int. J. Cardiol., 2015, 188: 99.

[5]

Li Z., Xie Z. Pfluügers Arch, 2009, 457: 635.

[6]

Prassas I., Diamandis E. P. Nat. Rev. Drug Discov., 2008, 7: 926.

[7]

Tian H. Y., Wang L., Zhang X. Q., Zhang D. M., Wang Y., Jiang R. W., Ye W. C. Steroids, 2010, 75: 884.

[8]

Tian H. Y., Wang L., Zhang X. Q., Wang Y., Zhang D. M., Jiang R. W., Liu Z., Liu J. S., Li Y. L., Ye W. C. Chem. Eur. J., 2010, 16: 10989.

[9]

Tian H. Y., Luo S. L., Liu J. S., Wang L., Wang Y., Zhang D. M., Zhang X. Q., Jiang R. W., Ye W. C. J. Nat. Prod., 2013, 76: 1842.

[10]

Li B. J., Tian H. Y., Zhang D. M., Lei Y. H., Wang L., Jiang R. W., Ye W. C. Fitoterapia, 2015, 105: 7.

[11]

Tian H. Y., Zhang P. W., Liu J. S., Zhang D. M., Zhang X. Q., Jiang R. W., Ye W. C. Chin. Chem. Lett., 2014, 25: 1104.

[12]

Cheng W., Tan Y. F., Tian H. Y., Gong X. W., Chen K. L., Jiang R. W. Nat. Prod. Res., 2014, 28: 901.

[13]

Zhang R. R., Tian H. Y., Tan Y. F., Chung T. Y., Sun X. H., Xia X., Ye W. C., Middleton D. A., Fedosova N., Esmann M., Tzen J. T. C., Jiang R. W. Org. Biomol. Chem., 2014, 12: 8919.

[14]

Tian H. Y., Yuan X. F., Jin L., Li J., Luo C., Ye W. C., Jiang R. W. Chem. Biol. Interact., 2014, 207: 16.

[15]

Zhang P. W., Tang H. J., Tian H. Y., Zhang R. R., Jiang R. W. Chin. J. Struct. Chem., 2014, 33: 1123.

[16]

Gobbini M., Armaroli S., Banfi L., Benicchio A., Carzana G., Fe-drizzi G., Ferrari P., Giacalone G., Giubileo M., Marazzi G., Miche-letti R., Moro B., Pozzi M., Scotti P. E., Torri M., Cerri A. J. Med. Chem., 2008, 51: 4601.

[17]

Aditya S., Rattan A. J. Pharmacol. Pharmacother., 2012, 3: 353.

[18]

Meng Q., Yau L. F., Lu J. G., Wu Z. Z., Zhang B. X., Wang J. R., Jiang Z. H. J. Ethnopharmacol., 2016, 187: 74.

[19]

Hirai Y., Morishita S., Ito C., Sakanashi M. Nihon Yakurigaku Zasshi, 1992, 100: 127.

[20]

Wang Z. J., Sun L., Heinbockel T. PLoS One, 2014, 9: e113272.

[21]

Zhang G., Wang C., Sun M., Li J., Wang B., Jin C., Hua P., Song G., Zhang Y., Nguyen L. L., Cui R., Liu R., Wang L., Zhang X. Onco-target, 2016, 7: 28935.

[22]

Li P., Song Q., Liu T., Wu Z., Chu X., Zhang X., Zhang Y., Gao Y., Zhang J., Chu L. Scientific World Journal, 2014, 2014: 496705.

[23]

Hao S., Bao Y. M., An L. J., Cheng W., Zhao R. G., Bi J., Wang H. S., Sun C. S., Liu J. W., Jiang B. Toxicol. in Vitro, 2011, 25: 1644.

[24]

Zhang Z., Li Z., Tian J., Jiang W., Wang Y., Zhang X., Li Z., You Q. D., Shapiro J. I., Si S., Xie Z. Mol. Pharmacol., 2010, 77: 961.

[25]

Xie Z., Wang Y., Liu G., Zolotarjova N., Periyasamy S. M., Askari A. Arch. Biochem. Biophys., 1996, 330: 153.

[26]

Brooks B. R., Bruccoleri R. E., Olafson B. D., States D. J., Swami-nathan S., Karplus M. J. Comp. Chem., 1983, 4: 187.

[27]

Dixon S. L., Merz K. M. Jr. J. Med. Chem., 2001, 44: 3795.

[28]

He X. J., Tang J. S., Qiao A. M., Wang G. H., Jiang M. M., Liu R. H., Yao X. S. Steroids, 2006, 71: 392.

AI Summary AI Mindmap
PDF

130

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/